Dallas, TX, United States
MPRX, Inc. dba Medical Park Pharmacy recalls
1 recall recorded since 2018, most recently on 18 December 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 18 December 2019
- Terminated
- 13 December 2022
- Reason
- Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
- Distribution
- TX
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0816-2020, D-0811-2020, D-0819-2020, D-0810-2020, D-0805-2020, D-0806-2020, D-0815-2020, D-0813-2020, D-0820-2020, D-0804-2020, D-0809-2020, D-0814-2020 and 6 more
- Squaric Acid 0.1% Topical Solution (Clinic) 30 mL
- Progesterone 200 mg Troche
- Tadalafil 6 mg Capsule
- Naltrexone 4.5 mg capsule
- Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars
- Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars
- Sildenafil 80 mg capsules
- Progesterone E4M SR 100 mg capsules
- and 10 more product lines
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.